血清钴和铬水平能否预测ASR髋关节表面置换术后患者报告结局
研究纳入62例ASR髋关节表面置换术后患者并每年随访,采用线性混合模型分析血清钴、铬水平与Harris髋关节评分及髋关节功能障碍与骨关节炎结局评分的关系,并用Kaplan-Meier和Cox回归评估十年翻修率。结果显示血清钴、铬每升高1 ppb与次年Harris髋关节评分及髋关节功能障碍与骨关节炎结局评分疼痛、生活质量亚量表恶化显著相关,队列十年生存率为65%(95%CI 52.5至77.6),血清钴水平的风险比为1.08(95%CI 1.01至1.15;p=0.028)。
要点
- 血清钴、铬每升高1 ppb与次年Harris髋关节评分恶化显著相关。
- 血清钴、铬升高同样与髋关节功能障碍与骨关节炎结局评分疼痛及生活质量亚量表恶化显著相关。
- 队列十年生存率65%(95%CI 52.5至77.6),血清钴水平风险比1.08(95%CI 1.01至1.15;p=0.028)。
核心结论
- ASR髋关节表面置换术后患者血清钴、铬水平升高可预测次年Harris髋关节评分和髋关节功能障碍与骨关节炎结局评分亚量表的恶化。
- 血清钴、铬升高应提醒外科医生和患者存在失败风险增高。
- 继续通过检测血清钴/铬水平和患者报告结局指标对ASR髋关节表面置换术后患者进行定期随访仍然必要。
研究设计与样本
- 研究纳入62例接受ASR髋关节表面置换术的患者,术后每年随访监测。
- 随访时测量血清钴和铬水平并评分Harris髋关节评分和髋关节功能障碍与骨关节炎结局评分。
- 记录术前患者和植入物变量及翻修手术需求,采用线性混合模型分析血清钴、铬水平与患者报告结局指标的关系。
- 生存分析采用Kaplan-Meier法和Cox回归模型。
主要发现
- 血清钴和铬水平每升高1 ppb与次年Harris髋关节评分恶化显著相关。
- 血清钴和铬水平每升高1 ppb与次年髋关节功能障碍与骨关节炎结局评分疼痛亚量表及生活质量亚量表恶化显著相关。
- 队列总体十年生存率为65%(95%CI 52.5至77.6)。
- Cox回归分析显示血清钴水平的风险比为1.08(95%CI 1.01至1.15;p=0.028),达统计学显著。
- 性别和倾斜角与翻修率无显著关联。
临床怎么用
- 作者认为,ASR髋关节表面置换术后患者血清钴、铬水平升高应提醒外科医生和患者存在失败风险增高。
- 作者认为,继续通过检测血清钴/铬水平和患者报告结局指标对ASR髋关节表面置换术后患者进行定期随访仍然必要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The aims of this study were to determine if an increasing serum cobalt (Co) and/or chromium (Cr) concentration is correlated with a decreasing Harris Hip Score (HHS) and Hip disability and Osteoarthritis Outcome Score (HOOS) in patients who received the Articular Surface Replacement (ASR) hip resurfacing arthroplasty (HRA), and to evaluate the ten-year revision rate and show if sex, inclination angle, and Co level influenced the revision rate. METHODS: A total of 62 patients with an ASR-HRA were included and monitored yearly postoperatively. At follow-up, serum Co and Cr levels were measured and the HHS and the HOOS were scored. In addition, preoperative patient and implant variables and the need for revision surgery were recorded. We used a linear mixed model to relate the serum Co and Cr levels to different patient-reported outcome measures (PROMs). For the survival analyses we used the Kaplan-Meier and Cox regression model. RESULTS: We found that an increase of one part per billion (ppb) in serum Co and Cr levels correlated significantly with worsening of the HHS in the following year. This significant correlation was also true for the HOOS-Pain and HOOS-quality of life sub scores. The overall ten-year survival rate in our cohort was 65% (95% confidence interval (CI) 52.5 to 77.6). Cox regression analysis showed a significant hazard ratio (HR) of 1.08 (95% CI 1.01 to 1.15; p = 0.028) for serum Co level. No significance was found with sex or inclination angle. CONCLUSION: This study shows that increasing serum Co and Cr levels measured in patients with an ASR-HRA are predictive for deterioration in HHS and HOOS subscales in the following year. Increasing serum Co and Cr should forewarn both surgeon and patient that there is a heightened risk of failure. Continued and regular review of patients with an ASR-HRA implant by measurement of serum Co/Cr levels and PROMs remains essential.
引用
- Koper MC, Spek RWA, Reijman M, et al. Are serum cobalt and chromium levels predictors for patient-reported outcome measures in the ASR hip resurfacing arthroplasty? Bone Joint J. 2023. PMID: 37394959. doi:10.1302/0301-620X.105B7.BJJ-2022-1359.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。